SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Nortran Pharmaceutical -NRT.V -- Ignore unavailable to you. Want to Upgrade?

To: Ms. Forthright who wrote (714)5/15/1998 8:17:00 AM
From: Mr. Forthright  Read Replies (1) | Respond to of 1185
 
You know who hold that stock? Who are these holders?



To: Ms. Forthright who wrote (714)5/15/1998 11:08:00 AM
From: Wisee  Read Replies (2) | Respond to of 1185
 
Ms. Forthright,

It was my pleasure to meet you & Edward at the AGM. We too were very impressed with Robert Rieder and Dr. Michael Walker's presentation.

After the AGM, we were very fortunate to meet several analysts that
are presently working on research reports on NRT.
They ALL agreed that NRT is presently undervalued!!
Expect BUY recommendations to come out shortly, with one year targets of between $4-$6.

Wisee



To: Ms. Forthright who wrote (714)5/16/1998 9:48:00 PM
From: Mr. Forthright  Respond to of 1185
 
<<I know who the investors are holding the private placements coming due next month. As you know, they are not quite the same as the junior mining types that Mr. F is familiar with.>>

I asked you last week to tell us who the holders are. Is the fact that the stock is all held by offshore companies making you nervous to answer my question? How would you know offshore buyers?

An answer would be appreciated.



HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News